7Baggers

DBV Technologies S.A
(NASDAQ:DBVT) 

DBVT stock logo

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergie...

Founded: 2002
Full Time Employees: 311
Sector: Healthcare
Industry: Biotechnology
Pharmaceuticals
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-01-29 2019-12-31 2019-06-30 2019-04-01 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31 
                                 
      operating income
    		2,774,000 1,465,000 753,000 511,000 1,072,000 1,161,000 1,407,000 8,875,000 2,372,000 2,288,000 2,194,000 -1,304,000 2,074,000 1,529,000 2,546,000 2,932,000 1,323,000 -1,488,000 2,941,000           
      yoy
    		158.77% 26.18% -46.48% -94.24% -54.81% -49.26% -35.87% -780.60% 14.37% 49.64% -13.83% -144.47% 56.76% -202.76% -13.43%               
      qoq
    		89.35% 94.56% 47.36% -52.33% -7.67% -17.48% -84.15% 274.16% 3.67% 4.28% -268.25% -162.87% 35.64% -39.95% -13.17% 121.62% -188.91% -150.60%            
      operating expenses
    		                             
      research and development expenses
    		-28,615,000 -33,693,000 -21,483,000 -18,904,000 -23,662,000 -25,374,000 -21,403,000 -12,775,000 -13,795,000 -17,616,000 -16,037,000 -29,613,000 -15,096,000 -18,611,000 -12,223,000 -11,673,000 -16,320,000 -20,179,000 -22,164,000           
      sales and marketing expenses
    		-1,178,000 -419,000 -262,000 -396,000 -519,000 -986,000 -758,000 -403,250 -663,000 -516,000 -434,000 -414,750 -159,000 -1,037,000 -464,000 -749,750 -1,072,000 -1,198,000 -729,000           
      general and administrative expenses
    		-7,259,000 -8,463,000 -5,626,000 -5,072,000 -7,220,000 -8,643,000 -7,804,000 -5,576,000 -6,184,000 -9,231,000 -6,889,000 -4,293,250 -4,839,000 -5,704,000 -6,630,000 -6,562,500 -8,299,000 -8,269,000 -9,683,000           
      total operating expenses
    		-37,051,000 -42,575,000 -27,370,000 -24,372,000 -31,401,000 -35,003,000 -29,964,000 -20,796,000 -20,642,000 -27,364,000 -23,359,000 -36,713,000 -20,094,000 -25,352,000 -19,317,000 -16,411,000 -25,691,000 -29,646,000 -32,575,000           
      income from operations
    		-34,277,000 -41,111,000 -26,618,000 -23,861,000 -30,328,000 -33,842,000 -28,558,000 -11,920,000 -18,270,000 -25,076,000 -21,165,000 -38,017,000 -18,020,000 -23,823,000 -16,771,000 -13,477,000 -24,368,000 -31,134,000 -29,634,000           
      financial income
    		1,113,000 -648,000 -461,000 853,000 -113,000 726,000 1,261,000 730,000 1,534,000 846,000 605,000 -1,241,000 732,000 784,000 152,000 -172,000 336,000 46,000 215,000           
      loss before taxes
    		-33,164,000 -41,758,000 -27,079,000 -23,008,000 -30,442,000 -33,116,000 -27,297,000 -11,192,000 -16,736,000 -24,230,000 -20,561,000 -39,258,000 -17,287,000 -23,039,000 -16,619,000 -13,649,000 -24,033,000 -31,088,000 -29,419,000           
      income tax
    		 -117,000  -7,000   -48,000 6,000  -13,000  17,000   -87,000 -23,000  434,000 -30,000 84,000 -74,000  -8,000 -15,000      
      net income
    		-33,164,000 -41,875,000 -27,079,000 -23,015,000 -30,442,000 -33,116,000 -27,345,000 -11,186,000 -16,736,000 -24,243,000 -20,561,000 -39,241,000 -17,287,000 -23,039,000 -16,706,000 -13,673,000 -24,033,000 -30,654,000 -29,449,000           
      yoy
    		8.94% 26.45% -0.97% 105.75% 81.90% 36.60% 32.99% -71.49% -3.19% 5.23% 23.08% 187.00% -28.07% -24.84% -43.27%               
      qoq
    		-20.80% 54.64% 17.66% -24.40% -8.07% 21.10% 144.46% -33.16% -30.97% 17.91% -47.60% 127.00% -24.97% 37.91% 22.18% -43.11% -21.60% 4.09%            
      foreign currency translation differences, net of taxes
    		-480,000 7,209,000 686,000 -4,020,000 3,825,000 -1,001,000 -3,026,000 6,261,000 -3,996,000 -221,000 3,666,000 20,323,000 -15,425,000 -11,394,000 -1,933,000 -2,612,000 -3,728,000 2,788,000 -8,744,000           
      actuarial gains or losses on employee benefits, net of taxes
    		-359,000                             
      comprehensive loss
    		-34,003,000 -34,841,000 -26,261,000             -23,457,500 -27,733,000 -27,818,000 -38,279,000           
      basic/diluted net loss per share attributable to shareholders
    		-0.24 -0.31 -0.26 -0.22 -0.32 -0.34 -0.28 -0.11 -0.17 -0.26 -0.22 -0.45 -0.18 -0.35 -0.3 -0.25 -0.44 -0.56 -0.54           
      weighted-average shares outstanding used in computing per share amounts:
    		136,811,952 134,476,503 102,617,429 96,995,379 96,201,476 96,170,285 96,176,057  96,075,540 94,324,889 93,970,598  93,905,050 66,047,949   54,947,354 54,904,764 54,880,776           
      actuarial gains on employee benefits, net of taxes
    		 -175,000 132,000 196,000 -41,000 67,000 -59,000 -19,000 73,000 -10,000 -82,000 -2,000 41,000 200,000  45,000 28,000 48,000 -85,000           
      total comprehensive loss
    		   -22,784,500 -26,658,000 -34,051,000 -30,429,000 -4,943,000 -20,659,000 -24,475,000 -16,977,000 -18,921,000 -32,672,000 -34,234,000 -18,615,000               
      actuarial gains (loss) on employee benefits, net of taxes
    		              24,000               
      weighted-average number of shares outstanding used in computing per share amounts:
    		       95,121,390    77,384,133   54,932,192 54,916,937    54,092,666          
      restructuring expenses
    		                             
      other comprehensive loss
    		                             
      revenues
    		                             
      other income
    		                   2,477,500 9,910,000  7,062,000 14,537,000      
      total income
    		                   2,477,500 9,910,000  7,062,000 14,537,000      
      cost of goods sold
    		                             
      research and development
    		                   -18,418,250 -73,673,000  -52,238,000       
      sales and marketing
    		                   -3,067,000 -12,268,000  -8,327,000       
      general and administrative
    		                   -8,700,750 -34,803,000  -25,825,000       
      total expenses
    		                   -30,186,250 -120,745,000  -86,389,000 -180,739,000      
      operating
    		                   -27,708,750 -110,835,000  -79,327,000 -166,202,000      
      financial revenues
    		                   124,500 498,000  491,000 493,000      
      financial expenses
    		                   129,000 -853,000  -966,000 -351,000      
      financial profit
    		                   -88,750 -355,000  -475,000 141,000      
      net
    		                   -27,816,000 -111,264,000  -79,810,000 -166,076,000      
      basic and diluted earnings per share
    		                   -0.818 -3.27  -2.43       
      research & development
    		                       -107,171,000      
      sales & marketing
    		                       -32,169,000      
      general & administrative
    		                       -41,399,000      
      basic/diluted
    		                       -5,740      
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-01-29 2019-12-31 2019-09-30 2019-06-30 2019-04-01 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31 2013-12-31 
                                     
        assets
      		                               
        current assets :
      		                               
        cash and cash equivalents
      		69,837,000 103,207,000 12,962,000 32,456,000 46,441,000 66,213,000 101,525,000 141,367,000 149,135,000 173,961,000 192,289,000 209,194,000 212,670,000 247,971,000 74,107,000 77,301,000 98,195,000 125,484,000 152,459,000 196,352,000  172,027,000   122,770,000 122,770,000 137,880,000 256,473,000 323,381 114,583,141  
        other current assets
      		19,045,000 18,034,000 16,186,000 11,932,000 22,318,000 23,745,000 18,037,000 17,548,000 20,136,000 21,578,000 17,946,000 13,880,000 13,025,000 11,981,000 16,329,000 37,085,000 11,943,000 13,107,000 7,349,000 8,792,000  8,021,000   21,131,000 21,131,000 17,721,000 14,454,000 11,512 6,722,563  
        total current assets
      		88,882,000 121,241,000 29,148,000 44,388,000 68,759,000 89,958,000 119,562,000 158,915,000 169,270,000 195,539,000 210,236,000 223,074,000 225,695,000 259,953,000 90,437,000 114,386,000 110,138,000 138,592,000 159,809,000 207,375,000 145,468 182,086,000  145,468 145,468,000 145,468,000 156,865,000 272,177,000 334,893 121,565,887  
        property, plant, and equipment
      		10,536,000 11,055,000 10,813,000 11,306,000 12,984,000 12,874,000 12,913,000 12,623,000 13,094,000 14,135,000 14,786,000 15,096,000 14,429,000 15,677,000 17,196,000 18,146,000 19,273,000 20,579,000 21,526,000 24,792,000 20,219 22,270,000  20,219 20,219,000 20,219,000 17,808,000 12,482,000 5,581 2,224,928  
        right-of-use assets related to operating leases
      		5,594,000 5,775,000 5,613,000 5,502,000 5,988,000 5,959,000 6,551,000 5,247,000 1,389,000 1,832,000 2,127,000 2,513,000 2,614,000 3,146,000  7,336,000 7,876,000 8,630,000 9,168,000 10,104,000            
        intangible assets
      		21,000 26,000 29,000 40,000 43,000 46,000 52,000 58,000 61,000 68,000 10,000 10,000 11,000 14,000 18,000 22,000 26,000 25,000 32,000 41,000 29 43,000  29 29,000 29,000 123,000 96,000 94 28,835  
        other non-current assets
      		5,462,000 5,333,000 4,960,000 4,423,000 5,280,000 5,353,000 6,818,000 6,144,000 5,970,000 5,944,000 5,771,000 5,824,000 5,368,000 6,189,000 6,575,000 6,833,000 33,612,000 32,758,000 30,870,000 29,935,000 6,033 16,488,000          
        total non-current assets
      		21,613,000 22,188,000 21,414,000 21,271,000 24,296,000 24,232,000 26,334,000 24,071,000 20,513,000 21,979,000 22,693,000 23,444,000 22,422,000 25,025,000 27,144,000 32,338,000 60,786,000 61,992,000 61,596,000 64,871,000 50,074 59,390,000  50,074 26,281,000 26,281,000 20,942,000 15,323,000 8,387 3,849,624  
        total assets
      		110,495,000 143,429,000 50,562,000 65,658,000 93,055,000 114,190,000 145,895,000 182,986,000 189,783,000 217,518,000 232,929,000 246,518,000 248,117,000 284,978,000 117,581,000 146,723,000 170,924,000 200,584,000 221,405,000 272,246,000 195,542 241,476,000  195,542 171,749,000 171,749,000 177,807,000 287,500,000 343,280 125,415,511 46,236,009 
        liabilities and shareholders' equity
      		                               
        current liabilities:
      		                               
        trade payables
      		39,816,000 40,792,000 34,146,000 22,032,000 22,500,000 19,818,000 18,076,000 23,302,000 16,654,000 19,094,000 19,938,000 14,473,000 15,369,000 16,341,000 11,416,000 11,429,000 12,170,000 16,335,000 17,176,000 20,338,000            
        short-term operating leases
      		1,001,000 998,000 709,000 654,000 374,000 380,000 232,000 1,144,000 1,522,000 1,944,000 1,923,000 1,894,000 1,381,000 1,968,000 2,034,000 3,003,000 2,657,000 2,761,000 3,314,000 3,708,000            
        current contingencies
      		218,000 117,000 82,000 122,000 253,000 1,023,000 3,153,000 3,959,000 4,596,000 5,076,000 4,142,000 3,944,000 3,026,000 3,189,000 3,529,000 4,095,000 5,633,000 6,227,000 4,246,000 5,016,000            
        other current liabilities
      		8,449,000 7,518,000 5,447,000 8,328,000 7,786,000 6,160,000 5,023,000 8,934,000 8,671,000 7,258,000 6,776,000 9,210,000 8,615,000 8,778,000 8,719,000 12,361,000 12,659,000 12,666,000 13,394,000 22,926,000 12,189 22,197,000  12,189 12,506,000 12,506,000 15,751,000 14,692,000 5,838 3,436,329  
        total current liabilities
      		49,485,000 49,425,000 40,384,000 31,136,000 30,913,000 27,381,000 26,483,000 37,339,000 31,443,000 33,373,000 32,778,000 29,521,000 28,391,000 30,431,000 26,031,000 31,397,000 33,814,000 38,698,000 38,831,000 52,713,000 46,200 48,068,000  46,200 43,543,000 43,543,000 35,930,000 29,002,000 16,021 5,551,650 4,234,096 
        long-term operating leases
      		6,690,000 6,696,000 6,525,000 6,297,000 7,038,000 6,783,000 6,793,000 4,526,000 94,000 187,000 680,000 1,127,000 1,423,000 1,945,000 2,268,000 7,147,000 8,298,000 9,155,000 9,533,000 10,496,000            
        non-current contingencies
      		1,466,000 1,084,000 780,000 838,000 1,070,000 931,000 965,000 935,000 11,553,000 15,731,000 15,989,000 16,680,000 5,272,000 6,421,000 5,758,000 6,758,000 7,629,000 6,064,000 2,229,000 2,527,000            
        total non-current liabilities
      		8,156,000 7,780,000 7,305,000 7,135,000 8,109,000 7,714,000 7,758,000 5,461,000 14,349,000 19,905,000 21,056,000 22,543,000 7,674,000 10,130,000  16,052,000 20,218,000 18,867,000 13,398,000 14,042,000 28,055 21,845,000  28,055 6,919,000 6,919,000 11,954,000 15,649,000 5,183 4,418,902  
        total liabilities
      		57,641,000 57,205,000 47,688,000 38,271,000 39,021,000 35,095,000 34,241,000 42,799,000 45,792,000 53,277,000 53,834,000 52,064,000 36,065,000 40,562,000 35,519,000 47,449,000 54,033,000 57,565,000 52,229,000 66,754,000           5,841,324 
        shareholders’ equity :
      		                               
        ordinary shares, €0.10 par value; 136,975,159 and 102,847,501 shares authorized, and issued as at september 30, 2025 and december 31, 2024, respectively
      		15,394,000                               
        additional paid-in capital
      		392,062,000 391,546,000 317,313,000 315,613,000 316,102,000 314,513,000 379,426,000 377,468,000 376,249,000 375,759,000 459,852,000 458,221,000 456,884,000 456,447,000 359,478,000 358,115,000 359,081,000 357,530,000 1,153,516,000 1,152,042,000            
        treasury stock
      		-1,123,000 -1,238,000 -1,263,000 -1,309,000 -1,351,000 -1,358,000 -1,325,000 -1,263,000 -1,163,000 -1,082,000 -1,123,000 -1,109,000 -1,083,000 -953,000 -1,193,000 -1,232,000 -810,000 -866,000 -681,000 -1,169,000            
        accumulated deficit
      		-348,301,000 -315,136,000 -313,454,000 -286,375,000 -263,332,000 -232,890,000 -266,207,000 -238,862,000 -227,677,000 -210,940,000 -280,138,000 -259,578,000 -220,337,000 -203,050,000 -275,219,000 -258,528,000 -244,856,000 -220,823,000 -987,992,000 -958,543,000            
        accumulated other comprehensive income
      		502,000 861,000 1,036,000 905,000 709,000 750,000 683,000 742,000 761,000 687,000 698,000 781,000 783,000 743,000 543,000 519,000 474,000 446,000 399,000 484,000            
        accumulated currency translation effect
      		-5,681,000 -5,202,000 -12,411,000 -13,097,000 -9,073,000 -12,898,000 -11,897,000 -8,871,000 -15,132,000 -11,136,000 -10,915,000 -14,581,000 -34,904,000 -19,480,000 -8,086,000 -6,137,000 -3,526,000 203,000 -2,586,000 6,158,000            
        total shareholders’ equity
      		52,854,000 86,224,000 2,873,000 27,387,000 54,034,000 79,095,000 111,654,000 140,187,000 143,991,000 164,240,000 179,094,000 194,453,000 212,052,000 244,416,000 82,062,000 99,274,000 116,892,000 143,019,000 169,176,000 205,491,000 121,286 171,563,000  121,286 121,286,000 121,286,000 129,923,000 242,849,000 322,076 115,444,959 40,394,685 
        total liabilities and shareholder's equity
      		110,495,000 143,429,000 50,562,000 65,658,000 93,055,000                           
        ordinary shares, €0.10 par value; 136,973,697 and 102,847,501 shares authorized, and issued as at june 30, 2025 and december 31, 2024, respectively
      		 15,393,000                              
        ordinary shares, €0.10 par value; 102,858,868 and 102,847,501 shares authorized, and issued as at march 31, 2025 and december 31, 2024, respectively
      		  11,652,000                             
        non-current liabilities:
      		                               
        shareholders’ equity:
      		                               
        ordinary shares, €0.10 par value; 102,847,501 and 96,431,770 shares authorized, and issued as at december 31, 2024 and december 31, 2023, respectively,
      		   11,651,000                            
        other non-current liabilities
      		        2,702,000 3,987,000 4,387,000 4,735,000 979,000 1,764,000 1,461,000 2,147,000 4,292,000 3,471,000 1,286,000 475,000 2,559 71,000  2,559 4,105,000 4,105,000 8,869,000 10,746,000    
        ordinary shares, €0.10 par value; 96,501,526 and 96,431,770 shares authorized, and issued as at september 30, 2024 and december 31, 2023, respectively
      		    10,979,000                           
        liabilities and shareholders’ equity
      		                               
        ordinary shares, €0.10 par value; 96,493,078 and 96,431,770 shares authorized, and issued as at june 30, 2024 and december 31, 2023, respectively
      		     10,978,000                          
        total liabilities and shareholder’s equity
      		     114,190,000         117,581,000    221,405,000 272,246,000            
        current assets:
      		                               
        ordinary shares, €0.10 par value; 96,434,369 and 96,431,770 shares authorized, and issued as of march 31, 2024 and december 31, 2023, respectively
      		      10,972,000                         
        total liabilities and shareholders’ equity
      		      145,895,000 182,986,000 189,783,000 217,518,000 232,929,000 246,518,000 248,117,000 284,978,000  146,723,000 170,924,000 200,584,000   195,542 241,476,000  195,542 171,749,000 171,749,000 177,807,000 287,500,000 343,280 125,415,511 46,236,009 
        trade receivables
      		                   2,230,000            
        current liabilities
      		                               
        short-term financial debt
      		             156,000 333,000 510,000 695,000 710,000 701,000 724,000 1,201 577,000  1,201 1,201,000 1,201,000 2,325,000 591,000 149 212,736  
        long-term financial debt
      		                 177,000 350,000 543,000 1,278 721,000  1,278 1,278,000 1,278,000 1,825,000 4,049,000 4,693 3,888,170  
        ordinary shares, €0.10 par value; 96,431,770 and 94,137,145 shares authorized, and issued as at december 31, 2023 and 2022, respectively
      		       10,972,000                        
        ordinary shares, €0.10 par value; 96,253,553 and 94,137,145 shares authorized, and issued as of september 30, 2023 and december 31, 2022, respectively
      		        10,953,000                       
        ordinary shares, €0.10 par value; 96,250,954 and 94,137,145 shares authorized, and issued as of june 30, 2023 and december 31, 2022, respectively
      		         10,952,000                      
        ordinary shares, €0.10 par value; 94,147,319 and 94,137,145 shares authorized, and issued as of march 31, 2023 and december 31, 2022, respectively
      		          10,721,000                     
        ordinary shares, €0.10 par value; 94,137,145 and 55,095,762 shares authorized, and issued as at december 31, 2022 and 2021, respectively
      		           10,720,000                    
        ordinary shares, €0.10 par value; 94,025,441 and 55,095,762 shares authorized, and issued as at september 30, 2022 and december 31, 2021, respectively
      		            10,709,000                   
        ordinary shares, €0.10 par value; 94,022,679 and 55,095,762 shares authorized, and issued as at june 30, 2022 and december 31, 2021, respectively
      		             10,708,000                  
        right of use assets related to operating leases
      		              3,356,000                 
        ordinary shares, €0.10 par value; 55,096,537 and 55,095,762 shares authorized, and issued as at march 31, 2022 and december 31, 2021, respectively
      		              6,539,000                 
        ordinary shares, €0.10 par value; 55,095,762 and 54,929,187 shares authorized, and issued as at december 31, 2021 and 2020, respectively, and 5,128,423 and 4,036,263 shares outstanding as at at december 31, 2021 and 2020, respectively
      		               6,538,000                
        ordinary shares, €0.10 par value; 55,011,687 and 54,929,187 shares authorized, and issued as at september 30, 2021 and december 31, 2020, respectively, and 3,946,548 and 4,029,763 shares outstanding as at september 30, 2021 and december 31, 2020, respectively
      		                6,529,000               
        ordinary shares, €0.10 par value; 55,011,687 and 54,929,187 shares authorized, and issued as at june 30, 2021 and december 31, 2020, respectively, and 3,943,548 and 4,029,763 shares outstanding as at june 30, 2021 and december 31, 2020, respectively
      		                 6,529,000              
        ordinary shares, €0.10 par value; 54,936,687 and 54,929,187 shares authorized, and issued as at march 31, 2021 and december 31, 2020, respectively, and 4,100,663 and 4,029,763 shares outstanding as at march 31, 2021 and december 31, 2020, respectively
      		                  6,519,000             
        inventories and work in progress
      		                             124,071  
        liabilities and shareholder’s equity
      		                               
        ordinary shares, €0.10 par value ; 54,929,187 and 47,028,510 shares authorized, and issued as at december 31, 2020 and 2019, respectively, and 4,036,263 and 4,026,688 shares outstanding as at december 31, 2020 and 2019, respectively
      		                   6,518,000            
        right-of-use assets related to leases
      		                    23,792 20,589,000  23,792        
        liabilities
      		                               
        shareholders’ equity
      		                               
        non-current liabilities
      		                               
        long-term lease debt
      		                    22,682 19,579,000  22,682        
        non-current provisions
      		                    1,536 1,474,000  1,536 1,536,000 1,536,000 1,260,000 853,000 490 530,732  
        short-term lease debt
      		                    2,973 3,282,000  2,973        
        current provisions
      		                    1,270 644,000  1,270 1,270,000 1,270,000 913,000     
        supplier accounts payable
      		                    28,567 21,368,000  28,567 28,567,000 28,567,000 16,941,000 13,720,000    
        non-current assets
      		                               
        current assets
      		                               
        inventories
      		                     2,038,000   1,566,000 1,566,000      
        customer accounts receivable and related receivables
      		                          1,265,000   136,112  
        share capital
      		                     4,703,000   3,016,000 3,016,000 2,499,000 2,465,000 2,421 1,916,066  
        premiums related to the share capital
      		                     725,460,000   539,292,000 539,292,000 406,709,000 405,882,000 403,910 163,876,789  
        reserves
      		                     -405,014,000   -254,946,000 -254,946,000 -131,592,000  -39,580 -26,336,016  
        net
      		                     -153,587,000   -166,076,000 -166,076,000 -147,693,000 -114,531,000 -44,674   
        bank overdrafts
      		                             27,956  
        other non-current financial assets
      		                       6,033 6,033,000 6,033,000 3,012,000 2,745,000 2,711 1,595,861  
        customer accounts receivable
      		                           1,250,000    
        reserve
      		                           -50,968,000    
        supplier accounts payable and related payables
      		                            10,034 1,874,629  
        net profit
      		                             -24,011,880  
        trade non-current liabilities
      		                              1,607,228 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2019-06-30 2019-04-01 
                              
          net loss for the period
        		-33,164,000 -41,875,000 -27,079,000 -23,015,000 -30,442,000 -33,116,000 -27,345,000 -11,186,000 -16,736,000 -24,243,000 -20,561,000 -39,241,000 -17,287,000   -13,673,000 -24,033,000 -30,654,000 -29,449,000    
          adjustments to reconcile net loss to net cash from operating activities:
        		              -16,706,000        
          depreciation, amortization and accrued contingencies
        		792,000 760,000 952,000 638,000 -152,000 -1,464,000 53,000 -10,926,000 -3,441,000 597,000 -228,000 12,022,000 -109,000 1,848,000 -599,000 -1,329,000 1,086,000 7,136,000 1,483,000    
          expenses related to share-based payments
        		516,000 1,245,000 1,702,000 -453,000 1,590,000 1,525,000 1,958,000 1,219,000 1,354,000 1,814,000 1,632,000 1,610,000 975,000 1,078,000 1,363,000 -956,000 1,551,000 1,094,000 1,433,000   25,904,000 
          inventory write-downs
        		3,680,000 5,965,000 4,286,000                    
          other elements
        		12,000 537,000 465,000 -585,000    0 0   -4,000 0 0 -3,000 -558,000 2,057,000 -387,000 -456,000   752,000 
          changes in operating assets and liabilities:
        		                      
          decrease in inventories and work in progress
        		-3,680,000 -5,965,000 -4,286,000                    
          decrease in other current assets
        		-994,000 -295,000 -3,662,000 8,782,000 1,830,000 -5,148,000 -835,000 2,055,000 631,000 -3,383,000 -3,098,000 61,000 -2,536,000 2,978,000 20,458,000 458,000 -643,000 -7,976,000 -417,000    
          increase in trade payables
        		-638,000 3,978,000 10,943,000 1,362,000 1,955,000 1,760,000 -4,805,000 6,729,000 -1,728,000 -1,059,000 4,478,000 -2,243,000 -195,000 5,913,000 -19,000 -424,000 -3,970,000 -598,000 -2,567,000    
          increase in other current and non-current liabilities
        		868,000 1,577,000 -3,104,000  1,352,000 1,188,000 -3,765,000 -2,787,000 366,000 76,000 -2,989,000 3,557,000 -365,000 1,078,000 -4,118,000 -2,102,000 1,111,000 1,372,000 -7,980,000    
          change in operating lease liabilities and right of use assets
        		174,000 168,000 115,000 -485,000 773,000 141,000 56,000 1,191,000 -64,000 577,000 -42,000 305,000 -575,000 -130,000 -1,849,000   -416,000 -353,000    
          net cash flow used in operating activities
        		-32,435,000           -23,885,000 -20,048,000 -10,250,000 -1,483,000 -18,790,000 -22,949,000 -30,299,000 -36,204,000   -136,620,000 
          cash flows from investing activities :
        		                      
          change in property, plant, and equipment
        		-117,000 -32,000 -10,000                    
          change in non-current financial assets
        		-125,000 -5,000 -366,000                    
          net cash flows from investing activities
        		-241,000 -38,000 -375,000   691,000 -2,132,000 -187,000 -322,000 -341,000 42,000 -34,000 152,000 -229,000 11,000 -474,000 54,000 172,000 -185,000   -8,641,000 
          cash flows from financing activities :
        		                      
          treasury shares
        		116,000 25,000 45,000 41,000 7,000 -33,000 -62,000 -208,000 27,000 41,000 -14,000 -26,000 -130,000 239,000 40,000 543,000 -997,000 60,000 578,000   -479,000 
          capital increases, net of transaction costs
        		14,000       19,000 -864,000   -261,000 -538,000   0 0 752,000 42,000   133,099,000 
          net cash flows from financing activities
        		130,000   675,000 7,000 -33,000 -62,000 -189,000 -837,000 7,807,000 -14,000 -283,000 -818,000 195,350,000 -129,000 377,000 -1,174,000 631,000 440,000   130,676,000 
          effect of exchange rate changes on cash and cash equivalents
        		-825,000 7,242,000 504,000 -3,203,000 2,788,000 -896,000 -2,957,000 6,294,000 -4,095,000 -241,000 3,909,000 20,725,000 -14,586,000 -11,006,000 -1,594,000 -2,008,000 -3,220,000 2,521,000 -7,944,000    
          net increase in cash and cash equivalents
        		-33,371,000 90,246,000 -19,494,000 -13,988,000 -19,771,000 -35,312,000 -39,842,000 -7,768,000 -24,827,000 -18,327,000 -16,905,000 -3,476,000 -35,301,000   -20,894,000 -27,289,000 -26,975,000 -43,893,000    
          net cash and cash equivalents at the beginning of the period
        		0 0 32,456,000 0 0 0 141,367,000 0 0 0 209,194,000 0 0 0 77,301,000 0 0 0 196,352,000   137,880,000 
          net cash and cash equivalents at the end of the period
        		-33,370,000 90,245,000 12,962,000 -13,985,000 -19,772,000 -35,312,000 101,525,000 -7,768,000 -24,826,000 -18,328,000 192,289,000 -3,476,000 -35,301,000 173,864,000 74,107,000 -20,894,000 -27,289,000 -26,975,000 152,459,000    
          net cash flow (used in) operating activities
        		  -19,668,000                    
          cash flows (used) / provided by financing activities :
        		                      
          net cash flows (used) / provided by financing activities
        		  45,000                    
          retirement pension obligations
        		    54,000 41,000 -8,000 18,000 47,000 46,000 -35,000 47,000 44,000 23,000 -9,000 57,000 70,000     295,000 
          increase in other current liabilities
        		                      
          change in intangible assets
        		                      
          change in non-current assets
        		                      
          adjustments to reconcile net loss to net cash flow from operating activities:
        		                      
          net cash flow from operating activities
        		    -22,457,000 -35,073,000 -34,692,000  -19,573,000 -25,553,000 -20,841,000            
          acquisitions of property, plant, and equipment
        		    -396,000 -732,000 -1,335,000    -111,000 -12,000   -131,000       -4,710,000 
          proceeds from property, plant, and equipment dispositions
        		           5,000 0          
          acquisitions of non-current financial assets
        		      -858,000 -231,000 -27,000   26,000 130,000 -239,000 -40,000 -122,000   -1,000   -3,890,000 
          proceeds of non-current financial assets dispositions
        		    458,000                  
          net cash flows from (used in) investing activities
        		                      
          increase in conditional advances
        		               -171,000 -173,000 -181,000 -164,000    
          cash flows from investing activities:
        		                      
          proceeds from non-current financial assets dispositions
        		      62,000 396,000 -246,000 -149,000 153,000            
          cash flows from financing activities:
        		                      
          decrease in trade receivables
        		               -24,000 -1,000 74,000 2,101,000    
          acquisitions of intangible assets
        		               0      -41,000 
          other cash flows related to financing activities
        		               6,000 -4,000 0 -17,000   -144,000 
          acquisitions of property, plant, and equipment, net from proceeds
        		        -50,000        59,000 171,000 -184,000    
          decrease in conditional advances
        		            -151,000          
          acquisition of intangible assets
        		                      
          proceeds from non-current financial assets
        		            396,000 247,000 179,000        
          proceeds from property, plant and equipment dispositions
        		              3,000        
          (decrease) in conditional advances
        		              -168,000       -1,800,000 
          net decrease in cash and cash equivalents
        		              -3,194,000        
          change in operating lease liabilities and right—of—use assets
        		                      
          acquisitions of property, plant, and equipment, net form proceeds
        		                      
          net
        		                      
          actuarial gains and losses on employee benefits, net of corporate tax
        		                      
          gain directly recognized in shareholders’ equity
        		                      
          other comprehensive income
        		                      
          total comprehensive
        		                      
          net profit for the period
        		                      
          reconciliation of the net profit (or loss) and the cash from the operating activities:
        		                      
          amortization and depreciation
        		                      
          expenses related to share-based compensation
        		                      
          operating cash flows before change in working capital
        		                     -136,294,000 
          inventories
        		                     -1,566,000 
          customer accounts receivable
        		                     1,229,000 
          other current and non-current assets
        		                      
          supplier accounts payable
        		                     9,095,000 
          other current and non-current liabilities
        		                     -6,493,000 
          change in working capital requirement
        		                     -326,000 
          cash flows from investing activities
        		                      
          net cash flows from investment activities
        		                      
          cash flows from financing activities
        		                      
          repayment of lease liabilities
        		                      
          interest paid on lease liabilities
        		                      
          (decrease) in cash
        		                     -14,586,000 
          cash and cash equivalents at beginning period
        		                      
          impact of exchange rate fluctuations
        		                     -525,000 
          cash and cash equivalents at the close of the period
        		                      
          net (loss) for the period
        		                     -166,076,000 
          reconciliation of the net (loss) and the cash from operating activities:
        		                      
          cash flows from operating activities:
        		                      
          amortization and provision
        		                     2,830,000 
          other current assets
        		                     -2,591,000 
          increase in cash
        		                      
          net cash and cash equivalents at the close of the period
        		                     122,770,000 
          reconciliation of the net (loss) and the cash from the operating activities:
        		                      
          at january 1, 2016
        		                     -39,580,000 
          foreign exchange translation
        		                     -743,000 
          profit directly recognized in shareholders’ equity
        		                     -249,000 
          total (loss) directly recognized in shareholders’ equity
        		                     -992,000 
          allocation of prior
        		                     -44,674,000 
          increase in capital
        		                      
          issue of share warrants
        		                      
          share-based payments
        		                     34,353,000 
          at december 31, 2016
        		                     -50,968,000 
          (loss) directly recognized in shareholders’ equity
        		                     -177,000 
          at december 31, 2017
        		                     -131,592,000 
          at december 31, 2018
        		                     -254,946,000 
          patents, licenses, trademarks
        		                      
          software
        		                      
          total historical cost
        		                      
          accumulated amort. of patents, licenses, and trademarks
        		                      
          accumulated depreciation of software packages
        		                      
          accumulated amortization and depreciation
        		                      
          net total
        		                      
          cash flows used in operating activities:
        		                      
          cash flows used in investing activities:
        		                      
          net cash flows used in investing activities
        		                      
          net cash at the beginning of the period
        		                      
          net cash at the close of the period
        		                      
          at january 1, 2015
        		                      
          at december 31, 2015
        		                      
          total, gross
        		                      
          accumulated amortization of patents, licenses, and trademarks
        		                      
          total